Critical illness-associated cerebral microbleeds: What we learned after the COVID-19 pandemic. A systematic review.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 03 05 2023
revised: 22 09 2023
accepted: 28 09 2023
medline: 20 11 2023
pubmed: 2 10 2023
entrez: 2 10 2023
Statut: ppublish

Résumé

Cerebral microbleeds in critically ill patients have been a reported complication of COVID-19. However, they have also been described in patients with other respiratory infections and conditions requiring intensive care unit (ICU) admission. Here, we aim to describe the clinical characteristics of critical illness-associated cerebral microbleeds and compare COVID-19 cases with those related to other conditions. We performed a systematic literature review in PubMed and Embase for Critical Illness-Associated Cerebral Microbleeds to describe the clinical characteristics of this entity, in both COVID-19 and non-COVID-19 patients. Of 157 manuscripts screened, 23 were included, totalling 143 cases (median age 61, interquartile range [IQR] 54-66), 104 (73 %) men. SARS-CoV2-associated pneumonia was found in 105 (73 %) cases. The median ICU stay was 34 (IQR 26-42) days and the median mechanical ventilation time was 24 (IQR 14-35) days. Cerebral microbleeds were more frequently juxtacortical (79 %) or located in the corpus callosum (75 %) and deep white matter (71 %) for both COVID-19 and non-COVID-19 individuals, whilst brainstem location was more frequent in non-COVID-19 patients (37 % vs 13 %; p = 0.02). Non-COVID-19 patients were younger (median age 42, IQR 30-54 years) than COVID-19 patients (median age 62, IQR 57-67 years; p < 0.001), and the median platelet count was significantly higher (200,000; IQR 116,000-284,000 ng/dL) in COVID-19 patients than non-COVID-19 patients (50,000; IQR 39,000-61,000 ng/mL; (p < 0.001). In this systematic review, most patients presented respiratory failure with prolonged mechanical ventilation and ICU stay. Juxtacortical white matter and corpus callosum are characteristic locations of critical illness-associated microbleeds.

Sections du résumé

BACKGROUND BACKGROUND
Cerebral microbleeds in critically ill patients have been a reported complication of COVID-19. However, they have also been described in patients with other respiratory infections and conditions requiring intensive care unit (ICU) admission. Here, we aim to describe the clinical characteristics of critical illness-associated cerebral microbleeds and compare COVID-19 cases with those related to other conditions.
METHODS METHODS
We performed a systematic literature review in PubMed and Embase for Critical Illness-Associated Cerebral Microbleeds to describe the clinical characteristics of this entity, in both COVID-19 and non-COVID-19 patients.
RESULTS RESULTS
Of 157 manuscripts screened, 23 were included, totalling 143 cases (median age 61, interquartile range [IQR] 54-66), 104 (73 %) men. SARS-CoV2-associated pneumonia was found in 105 (73 %) cases. The median ICU stay was 34 (IQR 26-42) days and the median mechanical ventilation time was 24 (IQR 14-35) days. Cerebral microbleeds were more frequently juxtacortical (79 %) or located in the corpus callosum (75 %) and deep white matter (71 %) for both COVID-19 and non-COVID-19 individuals, whilst brainstem location was more frequent in non-COVID-19 patients (37 % vs 13 %; p = 0.02). Non-COVID-19 patients were younger (median age 42, IQR 30-54 years) than COVID-19 patients (median age 62, IQR 57-67 years; p < 0.001), and the median platelet count was significantly higher (200,000; IQR 116,000-284,000 ng/dL) in COVID-19 patients than non-COVID-19 patients (50,000; IQR 39,000-61,000 ng/mL; (p < 0.001).
CONCLUSIONS CONCLUSIONS
In this systematic review, most patients presented respiratory failure with prolonged mechanical ventilation and ICU stay. Juxtacortical white matter and corpus callosum are characteristic locations of critical illness-associated microbleeds.

Identifiants

pubmed: 37783069
pii: S0967-5868(23)00290-4
doi: 10.1016/j.jocn.2023.09.028
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-97

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eduardo Mariño (E)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain.

Carlos Hervás (C)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain.

Manuel Lorenzo (M)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain.

Carlos Corral (C)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain.

Blanca Fuentes (B)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain.

María Alonso de Leciñana (M)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain.

Jorge Rodríguez-Pardo (J)

Neurology Department and Stroke Center, Hospital La Paz Institute for Health Research, IdiPAZ (La Paz University Hospital), Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: jrpardodedonlebun@salud.madrid.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH